X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (184) 184
male (162) 162
female (154) 154
index medicus (148) 148
middle aged (141) 141
aged (128) 128
adult (119) 119
tuberculosis (117) 117
respiratory system (92) 92
aged, 80 and over (58) 58
retrospective studies (58) 58
risk factors (56) 56
diagnosis (53) 53
infectious diseases (52) 52
original (49) 49
original article (45) 45
medicine, general & internal (44) 44
내과학 (38) 38
pulmonary tuberculosis (34) 34
prognosis (32) 32
treatment outcome (32) 32
mortality (30) 30
republic of korea (30) 30
prevalence (29) 29
disease (28) 28
infection (28) 28
medicine (28) 28
research (28) 28
tuberculosis, pulmonary - diagnosis (27) 27
adolescent (26) 26
antitubercular agents - therapeutic use (26) 26
prospective studies (25) 25
time factors (25) 25
young adult (25) 25
care and treatment (24) 24
health aspects (24) 24
patients (24) 24
pneumonia (24) 24
respiratory tract diseases (24) 24
risk (24) 24
의학일반 (24) 24
lung diseases (23) 23
analysis (22) 22
chronic obstructive pulmonary disease (22) 22
korea (21) 21
cancer (20) 20
microbiology (20) 20
republic of korea - epidemiology (20) 20
tuberculosis, pulmonary - drug therapy (20) 20
drug therapy (19) 19
lung cancer (19) 19
mycobacterium-tuberculosis (19) 19
pulmonary/respiratory (19) 19
research article (19) 19
sputum - microbiology (19) 19
studies (19) 19
case-control studies (18) 18
respiratory agents (18) 18
bacterial infections and mycoses (17) 17
epidemiology (16) 16
hospitals (16) 16
immunology (16) 16
internal medicine (16) 16
multivariate analysis (16) 16
bronchoscopy (15) 15
confidence intervals (15) 15
copd (15) 15
drug resistance (15) 15
medical colleges (15) 15
nontuberculous mycobacteria (15) 15
odds ratio (15) 15
radiography (15) 15
therapy (15) 15
tomography, x-ray computed (15) 15
tuberculosis, pulmonary - epidemiology (15) 15
logistic models (14) 14
tuberculosis, multidrug-resistant - drug therapy (14) 14
chemotherapy (13) 13
lung neoplasms - pathology (13) 13
management (13) 13
smoking (13) 13
abridged index medicus (12) 12
follow-up studies (12) 12
incidence (12) 12
infections (12) 12
predictive value of tests (12) 12
recurrence (12) 12
tuberculosis, pulmonary - microbiology (12) 12
usage (12) 12
cohort studies (11) 11
comorbidity (11) 11
critical care medicine (11) 11
impact (11) 11
korea - epidemiology (11) 11
mycobacterium tuberculosis - isolation & purification (11) 11
patient outcomes (11) 11
polymerase chain reaction (11) 11
pulmonary disease, chronic obstructive - physiopathology (11) 11
severity of illness index (11) 11
surgery (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 2017, Volume 64, Issue 3, pp. 301 - 308
Journal Article
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 05/2019, Volume 19, Issue 5, pp. 468 - 469
Journal Article
by Ahmad, Nafees and Ahuja, Shama D and Akkerman, Onno W and Alffenaar, Jan-Willem C and Anderson, Laura F and Baghaei, Parvaneh and Bang, Didi and Barry, Pennan M and Bastos, Mayara L and Behera, Digamber and Benedetti, Andrea and Bisson, Gregory P and Boeree, Martin J and Bonnet, Maryline and Brode, Sarah K and Brust, James C M and Cai, Ying and Caumes, Eric and Cegielski, J Peter and Centis, Rosella and Chan, Pei-Chun and Chan, Edward D and Chang, Kwok-Chiu and Charles, Macarthur and Cirule, Andra and Dalcolmo, Margareth Pretti and D'Ambrosio, Lia and de Vries, Gerard and Dheda, Keertan and Esmail, Aliasgar and Flood, Jennifer and Fox, Gregory J and Fréchet-Jachym, Mathilde and Fregona, Geisa and Gayoso, Regina and Gegia, Medea and Gler, Maria Tarcela and Gu, Sue and Guglielmetti, Lorenzo and Holtz, Timothy H and Hughes, Jennifer and Isaakidis, Petros and Jarlsberg, Leah and Kempker, Russell R and Keshavjee, Salmaan and Khan, Faiz Ahmad and Kipiani, Maia and Koenig, Serena P and Koh, Won-Jung and Kritski, Afranio and Kuksa, Liga and Kvasnovsky, Charlotte L and Kwak, Nakwon and Lan, Zhiyi and Lange, Christoph and Laniado-Laborín, Rafael and Lee, Myungsun and Leimane, Vaira and Leung, Chi-Chiu and Leung, Eric Chung-Ching and Li, Pei Zhi and Lowenthal, Phil and Maciel, Ethel L and Marks, Suzanne M and Mase, Sundari and Mbuagbaw, Lawrence and Migliori, Giovanni B and Milanov, Vladimir and Miller, Ann C and Mitnick, Carole D and Modongo, Chawangwa and Mohr, Erika and Monedero, Ignacio and Nahid, Payam and Ndjeka, Norbert and O'Donnell, Max R and Padayatchi, Nesri and Palmero, Domingo and Pape, Jean William and Podewils, Laura J and Reynolds, Ian and Riekstina, Vija and Robert, Jérôme and Rodriguez, Maria and Seaworth, Barbara and Seung, Kwonjune J and Schnippel, Kathryn and Shim, Tae Sun and Singla, Rupak and Smith, Sarah E and Sotgiu, Giovanni and Sukhbaatar, Ganzaya and Tabarsi, Payam and Tiberi, Simon and Trajman, Anete and Trieu, Lisa and Udwadia, Zarir F and van der Werf, Tjip S and Veziris, Nicolas and Viiklepp, Piret and ... and The Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017 and Collaborative Grp Meta-Analysis In and Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017
The Lancet, ISSN 0140-6736, 09/2018, Volume 392, Issue 10150, pp. 821 - 834
Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of... 
DRUG | SURGERY | SOUTH-AFRICA | BEDAQUILINE | MEDICINE, GENERAL & INTERNAL | HIGH-RATES | MANAGEMENT | SAFETY | XDR-TB | REGIMENS | PROGRAM | Clofazimine - therapeutic use | Recurrence | Tuberculosis, Multidrug-Resistant - mortality | Linezolid - therapeutic use | Humans | Fluoroquinolones - therapeutic use | Tuberculosis, Pulmonary - drug therapy | Kanamycin - therapeutic use | Moxifloxacin | Capreomycin - therapeutic use | Amikacin - therapeutic use | Carbapenems - therapeutic use | Tuberculosis, Pulmonary - mortality | Diarylquinolines - therapeutic use | Treatment Failure | Antitubercular Agents - administration & dosage | Levofloxacin - therapeutic use | Drug Therapy, Combination | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - drug therapy | Drug resistance in microorganisms | Care and treatment | Tuberculosis | Patient outcomes | Analysis | Drugs | Fluoroquinolones | Linezolid | Levofloxacin | Amikacin | Medical services | Clinical trials | Systematic review | Drug resistance | Success | Clinical outcomes | Literature reviews | Heterogeneity | Kanamycin | Data analysis | Clofazimine | Adjustment | Mortality | Data processing | Thorax | Regression analysis | Disease control | Patients | Capreomycin | Meta-analysis | Studies | Multidrug resistant organisms | Infectious diseases | Adults | Respiration | Carbapenems
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2013, Volume 131, Issue 6, pp. 1611 - 1623.e3
Background Mutations in signal transducer and activator of transcription (STAT) 1 cause a broad spectrum of disease, ranging from severe viral and bacterial... 
Allergy and Immunology | Signal transducer and activator of transcription 1 | regulatory T cell | immune dysregulation–polyendocrinopathy–enteropathy–X-linked | chronic mucocutaneous candidiasis | forkhead box protein 3 | aneurysms | immune dysregulation-polyendocrinopathy-enteropathy-X-linked | IMMUNOLOGY | DEFICIENCY | DISEASES | ALLERGY | REGULATORY T-CELLS | IPEX | EXPRESSION | IMMUNODEFICIENCY | T-Lymphocytes, Regulatory - metabolism | Polyendocrinopathies, Autoimmune - diagnosis | Humans | Transcriptional Activation | Interleukin-17 - immunology | Child, Preschool | Male | Intestinal Diseases - immunology | Lymphocyte Subsets - immunology | T-Lymphocytes, Regulatory - immunology | Lymphocyte Subsets - metabolism | STAT1 Transcription Factor - metabolism | Genes, Dominant | Th17 Cells - metabolism | Interleukins - immunology | Female | Genetic Diseases, X-Linked - genetics | Polyendocrinopathies, Autoimmune - genetics | Phosphorylation - drug effects | Child | Intestinal Diseases - genetics | Immunophenotyping | DNA - metabolism | Forkhead Transcription Factors - genetics | STAT1 Transcription Factor - genetics | Genetic Diseases, X-Linked - diagnosis | Syndrome | Interferon-alpha - immunology | Polyendocrinopathies, Autoimmune - immunology | Genetic Diseases, X-Linked - immunology | Intestinal Diseases - diagnosis | Autoantibodies - immunology | Phenotype | Adolescent | Th17 Cells - immunology | Mutation | Cell Line, Transformed | Interferon-gamma - pharmacology | Autoimmunity | Medical colleges | Invisibility | Molecular genetics | Mycoses | Aneurysms | Genetic aspects | Children | Health aspects
Journal Article
by Hobbs, B.D and Jong, Kim and Lamontagne, M and Bossé, Yohan and Shrine, Nick and Artigas, M.S and Wain, L.V and Hall, Ian and Jackson, V.E and Wyss, A.B and London, S.J and North, Kari and Franceschini, Nora and Strachan, David and Beaty, Terri and Hokanson, J.E and Crapo, Robert and Castaldi, P.J and Chase, R.P and Bartz, Traci M and Heckbert, Susan and Psaty, B.M and Gharib, Sina and Zanen, Pieter and Lammers, Jan-Willem and Oudkerk, Matthijs and Groen, Henk and Locantore, Nicholas and Tal-Singer, R and Rennard, S.I and Vestbo, Jorgen and Timens, Wim and Paré, Peter and Latourelle, Jeanne and Dupuis, Josée and O'Connor, George and Wilk, Jemma and Kim, W.J and Lee, M.K and Oh, Yeon-Mok and Vonk, Judith and Koning, Harry and Leng, S and Belinsky, S.A and Tesfaigzi, Y and Manichaikul, A and Wang, X.-Q and Rich, Stephen and Barr, Graham and Sparrow, D and Litonjua, Augusto and Bakke, Arnold B and Gulsvik, Amund and Lahousse, Lies and Brusselle, Guy and Stricker, Bruno and Uitterlinden, Ané and Ampleford, E.J and Bleecker, E and Woouff, P.G and Meyers, D.A and Qiao, D and Lomas, D.A and Yim, J.-J and Kim, D.K and Hawrylkiewicz, I and Sliwinski, P and Hardin, M and Fingerlin, Tasha E and Schwartz, D.A and Postma, D.S and MacNee, W and Tobin, Martin and Silverman, Edwin and Boezen, Marike and Cho, Michael and UK BiLEVE Investigators and COPDGene Investigators and ECLIPSE Investigators and SPIROMICS Res Grp and Int COPD Genetics Network and LifeLines Investigators and Int COPD Genetics Consortium and SPIROMICS Research Group and International COPD Genetics Network Investigators and International COPD Genetics Consortium
Nature Genetics, ISSN 1061-4036, 03/2017, Volume 49, Issue 3, pp. 426 - 432
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2017, Volume 65, Issue 7, pp. 1077 - 1084
Background. The advent of macrolides has led to therapeutic advances in the treatment of Mycobacterium avium complex lung disease (MAC-LD). The aim of this... 
Mycobacterium avium complex | lung disease | macrolide | INFECTIOUS DISEASES | CLOFAZIMINE | MICROBIOLOGY | AZITHROMYCIN | IMMUNOLOGY | INTRACELLULARE | REGIMENS | FEATURES | THERAPY | CLINICAL-EFFICACY | INCLUDING CLARITHROMYCIN | PULMONARY INFECTION | EXPOSURE | Treatment outcome | Lung diseases | Patient outcomes | Analysis | Causes of | Macrolide antibiotics | Dosage and administration | Research | Drug therapy
Journal Article